Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a...
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer...
Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire NEW YORK, Aug. 5, 2024 NEW YORK, Aug. 5, 2024 /PRNewswire/ -- The Gross...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
| 12 | -0.0478 | -59.75 | 0.08 | 0.084 | 0.031 | 16403092 | 0.05923037 | CS |
| 26 | -0.5478 | -94.4482758621 | 0.58 | 0.727643 | 0.031 | 8544512 | 0.10183127 | CS |
| 52 | -2.0278 | -98.4368932039 | 2.06 | 3.17 | 0.031 | 5568092 | 0.43685645 | CS |
| 156 | -12.8678 | -99.7503875969 | 12.9 | 13.01 | 0.031 | 2687964 | 1.25879586 | CS |
| 260 | -9.0278 | -99.6445916115 | 9.06 | 34.67 | 0.031 | 1983474 | 3.64569466 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
